Page-4 of Covishield Current Affairs, GK & News

Covishield Dose Interval to be Increased

The health Ministry has decided to increase the interval between first and second doses of Covishield to up to eight weeks in the ongoing covid-19 vaccination drive. Highlights This decision was taken following the data of the global trials of AZD122 which shows that extending the duration of doses to 12 weeks has increased its ..

Month: 

Category: 

Topics: 

‘Vaccine Maitri Initiative’ extended to Sri Lanka

India has extended its “Vaccine Maitri Initiative” to Sri-Lanka now. As per the agreement, India dispatched 500000 doses of Covishield vaccines to Sri Lanka as grant assistance. The vaccine maitri initiative has delivered nearly five million doses to seven countries in the neighbourhood, till date. Background The delivery of vaccines which has been made by ..

Month: 

Category: 

Topics: 

India approved two COVID-19 vaccines for Emergency Use

The Drug Controller General of India recently announced that it has authorised two COVID-19 vaccines for restricted Emergency Use in India. What are the two COVID-19 Vaccines approved by DGCI for emergency use? COVAXIN and COVISHIELD What is COVAXIN? The COVAXIN is the COVID-19 vaccine developed by Bharat Biotech and ICMR (Indian council of Medical ..

Month: 

Category: 

Topics: 

SII’s Covishield gets emergency-use nod from DGCI

The Subject Expert committee that is advising the Drug Controller General of India (DCGI) recommended restricted Emergency Use Authorisation for COVISHIELD. COVISHIELD vaccine was developed by Serum Institute of India. Who manufactures COVISHIELD? The COVISHIELD the vaccine is developed by the University of Oxford and the British Pharmaceutical major Astra Zeneca. In India, the vaccine ..

Month: 

Category: 

Topics: 

Mission COVID Suraksha: Key Facts

On November 12, 2020, the Finance Minister Nirmala Sitharaman announced Mission COVID Suraksha. Under the mission, the Government of India has allocated Rs 900 crores to the research and development of COVID-19 vaccines in India. The funds allocated do not cover the cost and distribution of the vaccines. Key Highlights The mission is a part ..

Month: 

Category: 

Topics: